JP2016523911A5 - - Google Patents

Download PDF

Info

Publication number
JP2016523911A5
JP2016523911A5 JP2016524175A JP2016524175A JP2016523911A5 JP 2016523911 A5 JP2016523911 A5 JP 2016523911A5 JP 2016524175 A JP2016524175 A JP 2016524175A JP 2016524175 A JP2016524175 A JP 2016524175A JP 2016523911 A5 JP2016523911 A5 JP 2016523911A5
Authority
JP
Japan
Prior art keywords
carboxamide
indole
methyl
methylphenyl
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016524175A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016523911A (ja
JP6509838B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/044247 external-priority patent/WO2014210255A1/en
Publication of JP2016523911A publication Critical patent/JP2016523911A/ja
Publication of JP2016523911A5 publication Critical patent/JP2016523911A5/ja
Application granted granted Critical
Publication of JP6509838B2 publication Critical patent/JP6509838B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016524175A 2013-06-26 2014-06-26 Btk阻害薬としての一級カルボキサミド類 Active JP6509838B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361839729P 2013-06-26 2013-06-26
US61/839,729 2013-06-26
US201361897577P 2013-10-30 2013-10-30
US61/897,577 2013-10-30
PCT/US2014/044247 WO2014210255A1 (en) 2013-06-26 2014-06-26 Primary carboxamides as btk inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019070362A Division JP6770127B2 (ja) 2013-06-26 2019-04-02 Btk阻害薬としての一級カルボキサミド類

Publications (3)

Publication Number Publication Date
JP2016523911A JP2016523911A (ja) 2016-08-12
JP2016523911A5 true JP2016523911A5 (enExample) 2017-08-03
JP6509838B2 JP6509838B2 (ja) 2019-05-08

Family

ID=52116191

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016524175A Active JP6509838B2 (ja) 2013-06-26 2014-06-26 Btk阻害薬としての一級カルボキサミド類
JP2019070362A Active JP6770127B2 (ja) 2013-06-26 2019-04-02 Btk阻害薬としての一級カルボキサミド類
JP2020159339A Pending JP2021001212A (ja) 2013-06-26 2020-09-24 Btk阻害薬としての一級カルボキサミド類

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019070362A Active JP6770127B2 (ja) 2013-06-26 2019-04-02 Btk阻害薬としての一級カルボキサミド類
JP2020159339A Pending JP2021001212A (ja) 2013-06-26 2020-09-24 Btk阻害薬としての一級カルボキサミド類

Country Status (28)

Country Link
US (4) US9567339B2 (enExample)
EP (3) EP4008328A1 (enExample)
JP (3) JP6509838B2 (enExample)
KR (1) KR102273997B1 (enExample)
CN (1) CN105530932B (enExample)
AU (3) AU2014302365B2 (enExample)
BR (1) BR112015032330B1 (enExample)
CA (1) CA2916298C (enExample)
CY (1) CY1121146T1 (enExample)
DK (1) DK3013337T3 (enExample)
ES (1) ES2708998T3 (enExample)
HR (1) HRP20190093T1 (enExample)
HU (1) HUE040645T2 (enExample)
IL (2) IL243332B (enExample)
LT (1) LT3013337T (enExample)
ME (1) ME03307B (enExample)
MX (1) MX355943B (enExample)
NZ (1) NZ754039A (enExample)
PL (1) PL3013337T3 (enExample)
PT (1) PT3013337T (enExample)
RS (1) RS58273B1 (enExample)
RU (1) RU2708395C2 (enExample)
SG (2) SG11201510503UA (enExample)
SI (1) SI3013337T1 (enExample)
TW (1) TWI642657B (enExample)
UY (1) UY35630A (enExample)
WO (1) WO2014210255A1 (enExample)
ZA (1) ZA201509012B (enExample)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY35464A (es) 2013-03-15 2014-10-31 Araxes Pharma Llc Inhibidores covalentes de kras g12c.
UY35630A (es) * 2013-06-26 2015-01-30 Abbvie Inc Carboxamidas primarias como inhibidores de btk
SI3052476T1 (sl) 2013-09-30 2020-12-31 Guangzhou Innocare Pharma Tech Co., Ltd. Substituirani nikotinimidni inhibitorji BTK in njihova priprava in uporaba pri zdravljenju raka, vnetja in avtoimunske bolezni
JO3805B1 (ar) 2013-10-10 2021-01-31 Araxes Pharma Llc مثبطات كراس جي12سي
CA2965517C (en) * 2014-10-24 2023-05-02 Bristol-Myers Squibb Company Indole carboxamides compounds useful as kinase inhibitors
AR104259A1 (es) * 2015-04-15 2017-07-05 Celgene Quanticel Res Inc Inhibidores de bromodominio
WO2017019429A1 (en) * 2015-07-27 2017-02-02 Eli Lilly And Company 7-phenylethylamino-4h-pyrimido[4,5-d][1,3]oxazin-2-one compounds and theit use as mutant idh1 inhibitors
WO2017070089A1 (en) 2015-10-19 2017-04-27 Incyte Corporation Heterocyclic compounds as immunomodulators
NZ741294A (en) * 2015-11-17 2023-07-28 Merck Patent Gmbh Methods for treating multiple sclerosis using pyrimidine and pyridine compounds with btk inhibitory activity
ES2928856T3 (es) 2015-11-19 2022-11-23 Incyte Corp Compuestos heterocíclicos como inmunomoduladores
WO2017106634A1 (en) 2015-12-17 2017-06-22 Incyte Corporation N-phenyl-pyridine-2-carboxamide derivatives and their use as pd-1/pd-l1 protein/protein interaction modulators
PT3889145T (pt) 2015-12-17 2024-04-02 Merck Patent Gmbh 8-ciano-5-piperidino-quinolinas como antagonistas de tlr7/8 e suas utilizações para tratamento de distúrbios imunitários
TWI850624B (zh) 2015-12-22 2024-08-01 美商英塞特公司 作為免疫調節劑之雜環化合物
ES2906460T3 (es) 2016-05-06 2022-04-18 Incyte Corp Compuestos heterocíclicos como inmunomoduladores
US20170335530A1 (en) * 2016-05-23 2017-11-23 Fatu K. Kofa Pet waste vacuum and disposal device and method
TW201808902A (zh) 2016-05-26 2018-03-16 美商英塞特公司 作為免疫調節劑之雜環化合物
CN106083707B (zh) * 2016-06-01 2018-10-26 温州大学 一种非对称杂芳基硫醚的合成方法
CN105837993A (zh) * 2016-06-01 2016-08-10 扬州兰都塑料科技有限公司 一种阻燃电力电缆用阻燃剂
CN105924840A (zh) * 2016-06-01 2016-09-07 扬州兰都塑料科技有限公司 一种阻燃电力电缆
CN105884673B (zh) * 2016-06-03 2018-05-11 温州大学 一种吲哚衍生物的合成方法
PT3472167T (pt) 2016-06-20 2022-11-11 Incyte Corp Compostos heterocíclicos como imunomoduladores
US20180016260A1 (en) 2016-07-14 2018-01-18 Incyte Corporation Heterocyclic compounds as immunomodulators
CN109563075B (zh) 2016-08-08 2022-09-30 默克专利股份公司 Tlr7/8拮抗剂及其用途
MA46045A (fr) 2016-08-29 2021-04-28 Incyte Corp Composés hétérocycliques utilisés comme immunomodulateurs
HRP20210066T1 (hr) * 2016-09-02 2021-03-05 Bristol-Myers Squibb Company Proces pripreme spoja indol karboksamida
WO2018068759A1 (zh) 2016-10-14 2018-04-19 江苏恒瑞医药股份有限公司 五元杂芳环并桥环类衍生物、其制备方法及其在医药上的应用
JP2020510624A (ja) 2016-12-12 2020-04-09 マルチビア インコーポレイテッド がんおよび感染性疾患の治療および予防のための、ウイルス遺伝子治療および免疫チェックポイント阻害剤を含む方法および組成物
RS63710B1 (sr) 2016-12-22 2022-11-30 Incyte Corp Derivati tetrahidro imidazo[4,5-c] piridina kao induktori internalizacije pd-l1
US20180179201A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Heterocyclic compounds as immunomodulators
EP3558973B1 (en) 2016-12-22 2021-09-15 Incyte Corporation Pyridine derivatives as immunomodulators
JP7101678B2 (ja) 2016-12-22 2022-07-15 インサイト・コーポレイション 免疫調節剤としての複素環式化合物
TW201835049A (zh) 2016-12-22 2018-10-01 美商英塞特公司 作為免疫調節劑之雜環化合物
EP3573964A1 (en) 2017-01-26 2019-12-04 Araxes Pharma LLC Benzothiophene and benzothiazole compounds and methods of use thereof
WO2018140598A1 (en) * 2017-01-26 2018-08-02 Araxes Pharma Llc Fused n-heterocyclic compounds and methods of use thereof
CN106928201B (zh) * 2017-02-22 2019-08-23 江汉大学 合成2-乙烯基吲哚衍生物的方法
CN110831933A (zh) 2017-05-25 2020-02-21 亚瑞克西斯制药公司 喹唑啉衍生物作为突变kras、hras或nras的调节剂
CN107098845A (zh) * 2017-07-06 2017-08-29 贵州大学 一种5‑氰基‑6‑硝基吲哚的制备工艺
CN107721988A (zh) * 2017-10-31 2018-02-23 无锡福祈制药有限公司 具有抗炎活性的异吲哚‑1‑酮类化合物
WO2019161152A1 (en) 2018-02-19 2019-08-22 Newave Pharmaceutical Inc. Inhibitors of btk and mutants thereof
RS66699B1 (sr) 2018-03-30 2025-05-30 Incyte Corp Heterociklična jedinjenja kao imunomodulatori
TW202425987A (zh) 2018-05-11 2024-07-01 美商英塞特公司 作為免疫調節劑之雜環化合物
CN112584833A (zh) 2018-08-01 2021-03-30 亚瑞克西斯制药公司 杂环螺化合物及其用于治疗癌症的使用方法
MX2021009863A (es) 2019-03-21 2021-11-12 Onxeo Una molecula dbait en combinacion con inhibidor de quinasa para el tratamiento del cancer.
TW202115059A (zh) 2019-08-09 2021-04-16 美商英塞特公司 Pd—1/pd—l1抑制劑之鹽
JP7559059B2 (ja) 2019-09-30 2024-10-01 インサイト・コーポレイション 免疫調節剤としてのピリド[3,2-d]ピリミジン化合物
WO2021089791A1 (en) 2019-11-08 2021-05-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
PH12022551136A1 (en) 2019-11-11 2023-10-09 Incyte Corp Salts and crystalline forms of a pd-1/pd-l1 inhibitor
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
US11807644B2 (en) 2020-05-12 2023-11-07 Pmv Pharmaceuticals, Inc. Methods and compounds for restoring mutant p53 function
JP2023528421A (ja) * 2020-06-02 2023-07-04 ジービー005, インコーポレイテッド キナーゼ阻害剤
BR112022025692A2 (pt) 2020-06-19 2023-02-28 Bayer Ag 1,3,4-oxadiazóis e seus derivados como fungicidas
CN116096414A (zh) 2020-08-04 2023-05-09 诺华股份有限公司 Cll的治疗
JP2023543299A (ja) 2020-09-30 2023-10-13 アストラゼネカ・アクチエボラーグ 化合物及び癌の治療におけるそれらの使用
US20230382900A1 (en) * 2020-10-30 2023-11-30 Newave Pharmaceutical Inc. Inhibitors of btk
US11780836B2 (en) 2020-11-06 2023-10-10 Incyte Corporation Process of preparing a PD-1/PD-L1 inhibitor
TW202233615A (zh) 2020-11-06 2022-09-01 美商英塞特公司 Pd—1/pd—l1抑制劑之結晶形式
TW202233616A (zh) 2020-11-06 2022-09-01 美商英塞特公司 用於製備pd-1/pd-l1抑制劑以及其鹽及結晶形式之方法
KR20230131251A (ko) * 2021-01-12 2023-09-12 쥐비005 인코포레이티드 키나아제 억제제로서의 인돌 유도체
CN114957241B (zh) * 2021-02-23 2023-08-22 药雅科技(上海)有限公司 杂环类化合物作为激酶抑制剂的制备及其应用
CN114853723B (zh) * 2021-02-03 2023-11-24 药雅科技(上海)有限公司 吲哚类化合物btk抑制剂的制备及其应用
CN114957242B (zh) * 2021-02-23 2023-08-22 药雅科技(上海)有限公司 吡啶并杂环类化合物作为激酶抑制剂的制备及其应用
US20240190864A1 (en) * 2021-02-03 2024-06-13 Ya Therapeutics Inc Bruton's Tyrosine Kinase (BTK) INHIBITOR AND APPLICATION THEREOF
CN114853752B (zh) * 2021-02-03 2023-08-22 药雅科技(上海)有限公司 Btk抑制剂吡啶并杂环类化合物的制备及其应用
CN116348453B (zh) * 2021-04-25 2025-07-04 烨辉医药科技(上海)有限公司 杂芳族甲酰胺化合物及其用途
CN115521313B (zh) * 2021-06-24 2023-11-03 山东大学 一种降解btk蛋白的化合物及其制备方法和应用
IL314122A (en) 2022-01-27 2024-09-01 Pmv Pharmaceuticals Inc Deuterium-converted compounds to restore mutant P53 activity
WO2023227080A1 (zh) * 2022-05-25 2023-11-30 百极弘烨(南通)医药科技有限公司 一种protac化合物、含其的药物组合物及其制备方法和应用
WO2023250431A2 (en) * 2022-06-22 2023-12-28 Children's Hospital Medical Center Multi-cyclic irak and flt3 inhibiting compounds and uses thereof
KR20250103814A (ko) * 2022-10-12 2025-07-07 메이즈 테라퓨틱스, 인코퍼레이티드 용질 담체 계열 6a 구성원 19(slc6a19)의 억제제 및 이의 사용 방법
KR102827002B1 (ko) * 2023-06-28 2025-06-30 국립순천대학교산학협력단 신규한 마리노바자난 화합물 및 이를 포함하는 암 전이 및 침윤 억제, 또는 암 치료용 조성물

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025510A (en) * 1975-12-01 1977-05-24 E. I. Du Pont De Nemours And Company 2,4-Diaryl[1,3,4H]thiadiazines fused to quinoxalines
US6090382A (en) 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
DE10022925A1 (de) 2000-05-11 2001-11-15 Basf Ag Substituierte Indole als PARP-Inhibitoren
US20040235867A1 (en) * 2001-07-24 2004-11-25 Bilodeau Mark T. Tyrosine kinase inhibitors
CA2502429A1 (en) * 2002-10-31 2004-05-21 Amgen Inc. Antiinflammation agents
WO2005012283A1 (en) 2003-07-31 2005-02-10 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzothiophene compounds and uses thereof
GB0400895D0 (en) * 2004-01-15 2004-02-18 Smithkline Beecham Corp Chemical compounds
CN1950377A (zh) * 2004-05-04 2007-04-18 霍夫曼-拉罗奇有限公司 作为ikk抑制剂的噻吩并吡啶类化合物
UY28945A1 (es) 2004-06-09 2006-01-31 Glaxo Group Ltd Derivados de pirrolopiridina
PE20060748A1 (es) * 2004-09-21 2006-10-01 Smithkline Beecham Corp Derivados de indolcarboxamida como inhibidores de quinasa ikk2
WO2006106326A1 (en) 2005-04-06 2006-10-12 Astrazeneca Ab Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
CN101189243A (zh) * 2005-04-06 2008-05-28 阿斯利康(瑞典)有限公司 取代的杂环及其作为chk1、pdk1和pak抑制剂的应用
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
MX2007016541A (es) * 2005-06-30 2008-03-07 Smithkline Beecham Corp Compuestos quimicos.
US20090275619A1 (en) 2006-04-03 2009-11-05 BOUERES Julia Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors
PE20081889A1 (es) * 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
EP2146967A2 (en) * 2007-04-16 2010-01-27 Serenex, Inc. Tetrahydroindole and tetrahydroindazole derivatives
WO2008132500A2 (en) * 2007-04-27 2008-11-06 Astrazeneca Ab Chkl inhibitors with b cell depleting antibodies for the treatment of hematologic malignancies
WO2008150490A2 (en) 2007-06-01 2008-12-11 Abbott Biotechnology Ltd. Uses and compositions for treatment of psoriasis and crohn's disease
CN101481380B (zh) * 2008-01-08 2012-10-17 浙江医药股份有限公司新昌制药厂 噻吩并哒嗪类化合物及其制备方法、药物组合物及其用途
AR070317A1 (es) 2008-02-06 2010-03-31 Osi Pharm Inc Furo (3,2-c) piridina y tieno (3,2-c) piridinas
US8338439B2 (en) 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
SG171815A1 (en) * 2008-12-19 2011-07-28 Bristol Myers Squibb Co Carbazole carboxamide compounds useful as kinase inhibitors
DK2473049T3 (en) 2009-09-04 2019-04-01 Biogen Ma Inc INHIBITORS OF BRUTON'S TYROSINKINASE
WO2011075699A2 (en) 2009-12-18 2011-06-23 Sunovion Pharmaceuticals Inc. Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
US20110212461A1 (en) 2010-02-26 2011-09-01 Hans Marcus Ludwig Bitter Prediction of cardiotoxicity
MX2012013378A (es) 2010-05-20 2013-01-24 Hoffmann La Roche Derivados de pirrolo [2, 3-b] pirazina-7-carboxamida y sus uso como inhibidores de cinasa janus (jak) y cinasa tirosina del brazo (syk).
US8685969B2 (en) * 2010-06-16 2014-04-01 Bristol-Myers Squibb Company Carboline carboxamide compounds useful as kinase inhibitors
WO2012009649A1 (en) 2010-07-16 2012-01-19 Anderson Gaweco Mif inhibitors and their uses
CN103209695A (zh) 2010-09-15 2013-07-17 弗·哈夫曼-拉罗切有限公司 氮杂苯并噻唑化合物、组合物及应用方法
FR2969151B1 (fr) * 2010-12-17 2016-11-04 Oreal Derives du 4-amino et leur utilisation pour la coloration d'oxydation des fibres keratiniques.
EP2696682B1 (en) 2011-04-13 2018-03-21 Innovimmune Biotherapeutics, Inc. Mif inhibitors and their uses
EP2561759A1 (en) * 2011-08-26 2013-02-27 Bayer Cropscience AG Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth
US9365566B2 (en) 2012-03-27 2016-06-14 Takeda Pharmaceutical Company Limited Cinnoline derivatives
UY35630A (es) * 2013-06-26 2015-01-30 Abbvie Inc Carboxamidas primarias como inhibidores de btk

Similar Documents

Publication Publication Date Title
JP2016523911A5 (enExample)
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
JP6218260B2 (ja) Jak阻害剤としてのアミノピリミジニル化合物
JP4638355B2 (ja) チアゾール誘導体
JP2023093623A (ja) Nav1.8阻害剤としての2-オキソイミダゾリジン-4-カルボキサミド
JP6964576B2 (ja) 置換4−アザインドール及びglun2b受容体調節因子としてのそれらの使用
HRP20200962T1 (hr) Novi spojevi
JP2019523233A5 (enExample)
JP2018513107A (ja) 1−(het)アリールスルホニル−(ピロリジン又はピペリジン)−2−カルボキサミド誘導体、及びtrpa1拮抗薬としてのそれらの使用
JP2019519484A5 (enExample)
JP2019535689A5 (enExample)
JP2017530960A5 (enExample)
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
JP2009529047A5 (enExample)
JP2017512794A5 (enExample)
RU2013145299A (ru) Тиазолопиримидины
RU2019132212A (ru) Селективные ингибиторы hdac6
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2013533868A (ja) タンパク質チロシンキナーゼ阻害剤としての新規ホモピペラジン誘導体およびそれらの医薬使用
JP7142675B2 (ja) Gpr6のモジュレーターとしてのピペリジニルおよびピペラジニル置換された複素芳香族カルボキサミド
JP2013533868A5 (enExample)
EA037598B1 (ru) Производные 3-((гетеро-)арил)-8-амино-2-оксо-1,3-диазаспиро[4,5]декана
JP2014513122A5 (enExample)
JP2019537581A5 (enExample)
JP2017516772A5 (enExample)